Stents Market Size, Trends, Analysis, and Outlook By Vascular Stents (Coronary Stents, Peripheral Stents (Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, Others), Neurovascular Stents (Intracranial Stents, Flow Dive

Stents Market Size, Trends, Analysis, and Outlook By Vascular Stents (Coronary Stents, Peripheral Stents (Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, Others), Neurovascular Stents (Intracranial Stents, Flow Diverters), By Non-vascular Stents (Gastrointestinal Stents (Biliary,Duodenal, Colonic, Pancreatic, Esophageal Stents), Pulmonary (Airway) Stents(Silicone Airway, Metallic Airway), Urological Stents, Others), By Material (Metallic Stents, Non-metallic Stents), By End-user ( Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics), by Region, Country, Segment, and Companies, 2024-2030

The global Stents market size is poised to register 6.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Stents market across By Vascular Stents (Coronary Stents, Peripheral Stents (Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, Others), Neurovascular Stents (Intracranial Stents, Flow Diverters), By Non-vascular Stents (Gastrointestinal Stents (Biliary,Duodenal, Colonic, Pancreatic, Esophageal Stents), Pulmonary (Airway) Stents(Silicone Airway, Metallic Airway), Urological Stents, Others), By Material (Metallic Stents, Non-metallic Stents), By End-user ( Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics).

The Stents market is experiencing steady growth due to the increasing prevalence of cardiovascular diseases, advancements in stent design and materials, and the growing adoption of minimally invasive interventional cardiology procedures. Stents are medical devices used to open narrowed or blocked blood vessels and restore blood flow to the heart, brain, or other parts of the body, thereby reducing the risk of heart attacks, strokes, and other cardiovascular events. Factors such as the expanding geriatric population, the rising incidence of coronary artery disease and peripheral artery disease, and the growing demand for stent-based treatments for complex lesions and high-risk patient populations are driving market expansion. Additionally, advancements in drug-eluting stents (DES), bioresorbable stents, and bifurcation stenting techniques, along with the development of next-generation stent coatings and drug delivery systems, are fueling innovation in the market. Moreover, the increasing adoption of percutaneous coronary intervention (PCI) procedures, the expanding indications for stent implantation, and the rising investments in clinical research and product development are driving market growth. Furthermore, efforts to improve stent safety, efficacy, and long-term outcomes, as well as the expansion of healthcare infrastructure and access to cardiovascular care in emerging economies, are expected to further propel market growth in the foreseeable future.

Stents Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Stents market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Stents survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Stents industry.

Key market trends defining the global Stents demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Stents Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Stents industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Stents companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Stents industry

Leading Stents companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Stents companies.

Stents Market Study- Strategic Analysis Review

The Stents market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Stents Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Stents industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Stents Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Stents Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Stents market segments. Similarly, Strong end-user demand is encouraging Canadian Stents companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Stents market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Stents Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Stents industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Stents market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Stents Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Stents in Asia Pacific. In particular, China, India, and South East Asian Stents markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Stents Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Stents Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Stents market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Stents.

Stents Market Company Profiles

The global Stents market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Biosensors International Group Ltd, Boston Scientific Corp, Elixir Medical Corp, Medtronic Plc, Meril Life Science, MicroPort Scientific Corp, Stryker, Terumo Corp, W.L Gore & Associates, BD, Conmed Corp

Recent Stents Market Developments

The global Stents market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Stents Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Vascular Stents

Coronary Stents

Peripheral Stents

Iliac Artery Stents

Femoral Artery Stents

Carotid Artery Stents

Renal Artery Stents

Others

Neurovascular Stents

Intracranial Stents

Flow Diverters

By Non-vascular Stents

Gastrointestinal Stents

Biliary

Duodenal

Colonic

Pancreatic

Esophageal Stents

Pulmonary (Airway) Stents

Silicone Airway

Metallic Airway

Urological Stents

Others

By Material

Metallic Stents

Non-metallic Stents

By End-user

Hospitals

Ambulatory Care Centers (ACS)

Specialty Clinics

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Abbott Laboratories

B. Braun Melsungen AG

Biotronik SE & Co. KG

Biosensors International Group Ltd

Boston Scientific Corp

Elixir Medical Corp

Medtronic Plc

Meril Life Science

MicroPort Scientific Corp

Stryker

Terumo Corp

W.L Gore & Associates

BD

Conmed Corp

Formats Available: Excel, PDF, and PPT